Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON)
Completed · Not applicable · NCT05591989
Conditions: Chronic Rhinitis
At a glance
- Research payments reported, 2025
- $53,513
- U.S. investigators named
- 0
- Sites paid
- 0
- Planned or actual enrollment
- 80
About the trial
- Sponsor
- Neurent Medical
- Tested
- NEUROMARK System (device)
- Dates
- Started 2022-09-26; completion 2025-08-05
- Results posted
- Not yet
The PARAGON Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.
From ClinicalTrials.gov, last updated 2026-05-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Neurent Medical Limited reported $53,513 in research payments for this study in 2025 (12 payments).
Products named: Neuromark Radiofrequency Console, Neuromark System
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $53,513
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.